Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Randomized Trial of Switch to Tenofovir Disoproxil-Based Regimen
2014-003419-12Phase 3Terminated
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in human immunodeficiency virus infection (HIV) comparing Switch to TDF/FTC/RPV (Eviplera) with Continue TDF/FTC/EFV (Atripla) (2 arms). Primary endpoint: Neurocognitive improvement rate. Started Jan 2015; status: terminated.
02
Drugs
emtricitabine + rilpivirine + tenofovir disoproxil fumaratetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-003419-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003419-12.